Pardes Biosciences, Inc. Profile Avatar - Palmy Investing

Pardes Biosciences, Inc.

Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 …

Biotechnology
US, Carlsbad [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of PRDS's Analysis
CIK: 1822711 CUSIP: 69945Q105 ISIN: US69945Q1058 LEI: - UEI: -
Secondary Listings
PRDS has no secondary listings inside our databases.